CV and PS related Flashcards

1
Q

1-Horiuchi K, Kuno T, Takagi H, Egorova NN, Afezolli D. Predictive value of the G8 screening tool for postoperative complications in older adults undergoing cancer surgery: A systematic review and meta-analysis. J Geriatr Oncol. April 2024;15(3):101656.

A

It was my strong desire to work on a research project to fill in the gaps between geriatrics and oncology. This is my very first one, mentored by the Department of Geriatrics and Palliative Medicine. By conducting a systematic review and meta-analysis, I explored the predictive value of the G8 screening tool for post operative complications in older adults who are undergoing cancer surgery. Happily, this was published in the Journal of Geriatric Oncology.
It was a great collaboration with my mentors and statistician, and such a great pleasure to work on a project that is in align with my career vision, based on my own clinical question.
G8; 0-17. Fit 17-15. Not fit 14-0.
Domains (8)-age, nutrition, physical, psychological, medication, and self-reported health.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

02-Horiuchi K, Fogel J. Challenges in diagnosing thoracic meningioma. BMJ Case Rep. April 2024;17(4):e257761.

A

This is one of my recent geriatric related case report, published in BMJ Case reports and also presented at AGS. This is an older patient presenting with progressive frailty disproportionate to his prior well-being, and imaging revealed a mass in the spinal canal. This was resected, and pathology confirmed meningioma. The take away from this case report is that even in older patients presenting with frailty, sometimes there is a reversible cause worth investigating.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

03-Horiuchi K, Ikemura S, Sato T, Shimozaki K, Okamori S, Yamada Y, Yokoyama Y, Hashimoto M, Jinzaki M, Hirai I, Funakoshi T,Mizuno R, Oya M, Hirata K, Hamamoto Y, Terai H, Yasuda H, Kawada I, Soejima K, Fukunaga K. Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis. Oncologist. January 2024;29(1):e108.

A

This is a single institution retrospective research to collect a real-world data to evaluate whether underlying interstitial lung abnormalities be a risk factor for pneumonitis, associated with immune checkpoint inhibitors. This was one of the exciting projects that I engaged in, since this was generated from my own clinical question and I took a leadership role. This research involved many cancer related departments including dermatology, urology, GI, pulmonology, hematology, and radiology. This experience was meaningful because a high level leadership, team building, and coordination were required, which I was able to build through the journey.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

04-Kim S, Horiuchi K, Arrazola E, Basnet A. Metastatic malignant melanoma presented as non-traumatic adrenal haemorrhage. BMJ Case Rep. June 2024;17(6):e260227.

A

This is one of the recent case report project that I mentored. A middle aged man came in with a flank pain, and imaging revealed adrenal hemorrhage. No clear etiology was found and patient was discharged. Several months later he presented with a seizure, and this time patient was found to have metastatic lesions in the brain and adrenal, which later was confirmed to be melanoma. The takeaway from this case is that adrenal hemorrhage could be an early sign of metastatic lesion, and should be investigated carefully.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

05-Kim S, Horiuchi K, Ueda T, Boku S. Significant efficacy of electroconvulsive therapy on the behavioural symptoms of anti-N-methyl-d-aspartate receptor encephalitis. BMJ Case Rep. February 2024;17(2):e258460.

A

This is one of the case report project that I mentored. A rare case of NMDA encephalitis with significant late phase psychotic features, and electroconvulsive therapy was attempted along with steroids. This was not a common indication for electroconvulsive therapy but ended up being effective, so we decided to publish the case.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

07-Horiuchi K, Fogel J, Sarmiento J. Endovenous radiofrequency ablation of great saphenous vein complicated by pulmonary embolism in an elderly patient. BMJ Case Rep. July 2023;16(7):e255543.

A

This was a case from two years ago. An older woman had varicose veins on the lower extremities, and and she underwent radiofrequency ablation, that was performed by vascular. Although she continued to take Eliquis for her afib and US doppler the day before procedure, per protocol, did not reveeal DVT, her course was complicated by PE/DVT. This case report was published to heighten awareness of this complication, with increased risk for older patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

06-Shichijo Y, Horiuchi K, Fogel J. Immune thrombocytopaenic purpura following COVID-19 infection masquerading as senile purpura. BMJ Case Rep. April 2024;17(4):e259747

A

This is one of the case report project that I mentored, which was geriatric related. An older woman presented with purpura. At first we thought that this was non-specific, but because it recurred, blood work was performed and revealed an extremely low platelet count. She was admitted for further work-up, but did not reveal any specific etiology. Further history revealed a COVID-19 infection earlier, and then was thought to be immune related 2/2 COVID. The takeaway is that if an older patient comes in with purpura with recent COVID infection, it maybe safer to check CBC for possible thrombocytopenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

09-Horiuchi K, Ikeda T, Kida A, Oyamada Y. Bilateral vocal cord paralysis due to direct invasion of right and left recurrent laryngeal nerves in a small cell lung cancer patient. BMJ Case Rep. August 2021;14(8):e245011.

A

This patient with stage 4 small cell lung cancer had a large mediastinal mass invading recurrent laryngeal nerves both right and left. He had a hoarse voice but still maintaining airway. There were extremely high risk of airway compromise so goals of care was discussed carefully. The takeaway for this case is that if there is concern for b/l vocal cord paralysis, GOC needs to be carefully discussed in advance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

08-Horiuchi K, Sato T, Kuno T, Takagi H, Hirsch FR, Powell CA, Fukunaga K. Platinum-doublet chemotherapy as second-line treatment for relapsed patients with small-cell lung cancer: A systematic review and meta-analysis. Lung Cancer. June 2021;156(1):59.

A

This is a meta-analysis evaluating the effectiveness of platinum-doublet re-challenge in the second line for the treatment for small cell lung cancer. I came up with this clinical question as a thoracic medical oncologist, and along with my team we decided to conduct a meta-analysis. It was such an exciting process, gathering publications, extracting data, and we came up with some beautiful figures. This meta-analysis supported the use of rechallenge regimen in the second line, which I believe has a remarkable impact.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

10-Akiyama Y, Horiuchi K, Kondo Y, Kabata H, Ishii M, Fukunaga K. A case of non-severe COVID-19 complicated by pulmonary embolism. Respirol Case Rep. July 2020;8(7):e00622.

A

This is one of the case report projects that I mentored. This patient had non-severe COVID-19, and it was complicated by pulmonary embolism. At the time, thromboembolism was mainly reported in severe cases, so we published this complication. This is one of the first projects that I served as a mentor, where I explored my roles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

11-Horiuchi K, Asakura T, Sakaguchi S, Saito F. Bilateral chylothorax associated with osteophytes in an elderly patient. BMJ Case Rep. April 2019;12(4):e229473.

A

It was when I was PGY5 that I experienced this case. This patient was brought in for shortness of breath, and further work up revealed bilateral chylothorax. Lymphangiography was performed, and we found a leakage near an osteophyte of the vertebra, suggestive as a cause for damage after a blunt trauma. This mechanism for chylothorax was not reported in previous literature, so we published the case.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

12-Horiuchi K, Asakura T, Ochi J, Saito F. Pneumothorax associated with giant bullous emphysema and mediastinum deviation. BMJ Case Rep. December 2019;12(12):e230353.

A

It was when I was PGY 5 that I experienced this case. This patient was brought in for shortness of breath, and further work-up revealed pneumothorax and a deviated mediastinum, a condition suspicious for tension pneumothorax. However, the deviation persisted even after chest tube insertion. We discussed here that the chronic deviation may have been due to a unilateral giant bullous emphysema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

13-Horiuchi K, Asakura T, Ikeda N. Rhabdomyolysis diagnosed in an older woman with dementia on examination after a wandering episode. Geriatr Gerontol Int. September 2019;19(9):956.

A

It was when I was PGY 5 that I experienced the case. This patient in her 80s with dementia, was brought in by ambulance, unable to walk on a street. Further work-up revealed an elevated CPK of 15,000. We were not totally sure why she had rhabdo. Thereafter, detailed history obtained from her revealed her wandering episode. This case report published to notify the importance of careful history taking in an elderly patient with rhabdomyolysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

14-Horiuchi K, Asakura T, Sakaguchi S, Saito F. Successful osimertinib treatment in a patient who exhibited intramedullary spinal cord metastases of lung adenocarcinoma with an acquired EGFR T790M mutation. BMJ Case Rep. June 2019;12(6):e229310.

A

It was when I was PGY 5 that I experienced this case. This patient with lung cancer had an extremely rare site of metastasis – intramedullary spinal cord. The use of Osimertinib, an EGFR tyrosine kinase inhibitor, demonstrated remarkable response and the tumor almost vanished. We published this case to share its unusual treatment course.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

15-Horiuchi K, Asakura T, Sakaguchi S, Saito F, Yamamoto J. Placental transmogrification of the lung masquerading as difficult-to-treat pneumonia. QJM. March 2020;113(3):213.

A

It was when I was PGY 5 that I experienced this case. This patient presented with difficult-to-treat pneumonia, showing no response to antibiotics nor systemic steroids. Surgical resection of the consolidation revealed an extremely rare pathology - placental transmogrification of the lung. This is abnormal tissue resembling placenta without any function. We published this case to share its unusual presentation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

16-Horiuchi K, Asakura T, Bessho Y, Saito F. Infectious tenosynovitis of the long head of the biceps caused by methicillin-resistant Staphylococcus aureus in a patient with diabetes and small cell lung cancer. BMJ Case Rep. March 2019;12(3):e229040.

A

It was when I was PGY 5 that I experienced this case. This patient with diabetes and small cell lung cancer presented with fever, and further work-up revealed an infectious tenosynovitis of the long head of the biceps caused by MRSA. This was such a rare site of infection, so I published the case. It may be related with the use of insulin injection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

17-Horiuchi K, Asakura T, Saito F, Asakura T. Superior vena cava syndrome. QJM. September 2019;112(9):703.

A

When I was doing outpatient clinic service, one older man came complaining distended vessels on his chest, and he was an active smoker. I soon realized that that could be SVC syndrome, and x ray performed on the same day revealed a mediastinum mass, concerning for lung cancer. Pictures of dermatologic features for SVC syndrome were not well reported in the literature, so I decided to publish for educational purpose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

18-Horiuchi K, Asakura T, Sakaguchi S, Saito F. Lung cancer masquerading as fungus-associated mucoid impaction. BMJ Case Rep. December 2018;11(1):e227470.

A

It was when I was PGY 5 that I experienced this case. This patient presented with slight cough and chest images revealed a localized mucoid impaction of the lung. Follow-up over several months revealed an emerging mass at the site, and bronchoscopy revealed lung cancer. This was a rare presentation for lung cancer, so we published the case.

19
Q

19-Horiuchi K, Asakura T, Hasegawa N, Saito F. Recurrence of allergic bronchopulmonary aspergillosis after adjunctive surgery for aspergilloma: a case report with long-term follow-up. BMC Pulm Med. December 2018;18(1):185.

A

It was when I was PGY 5 that I experienced this case. This patient had both aspergilloma and ABPA under a condition called aspergillus march. Surgical resection of aspergilloma led to control of ABPA. The treatment course was unique, so I published the case for a guidance to clinicians.

20
Q

01- Horiuchi K, Hortelano C, Nikfar R, Fogel J. Hereditary transthyretin-mediated amyloidosis masquerading as diabetic neuropathy and lumbar radiculopathy. BMJ Case Rep. June 2024.

A

This is my most recent geriatric related case report is under review by BMJ Case reports and also present at AGS. Older man with diabetes and lumbar radiculopathy presented with progressive frailty becoming wheel chair bound. At first, we had an impression that this could be a combination of diabetes and radiculopathy, but the way his function declined was disproportionately progressive. But he also had hx of carpal tunnel syndrome and HFpEF. We made our effort to “connect the dots”, and raised our suspicion for amyloidosis. Later sural nerve biopsy confirmed the diagnosis. I realized that there may be a strong anchor bias towards initial diagnosis, but sometimes that has to be re-visited.

21
Q

02- Goto T, Horiuchi K, Hui J. Spontaneous paraspinal muscle hematoma in an older woman with ANCA-associated glomerulonephritis. QJM. June 2024.

A

This is one of the case report project that I have been mentoring, which is under review by a journal and presented at the Society of General Internal Medicine. A middle aged man who was initially admitted for renal failure requiring HD, had a sudden onset flank pain during the hospital course. Clinically the reason was not clear but notably had a drop in Hgb, so CT with contrast was obtained. Image revealed a paraspinal muscle hematoma. Non-traumatic etiology is extremely rare, so we decided to publish the case.

22
Q

03- Horiuchi K, Mulholland C. Urinary obstruction at end of life after withdrawal from hemodialysis in an older man. Geriatr Gerontol Int. January 2024.

A

This is about an older patent who decided to withdraw from HD. His wishes were appreciated by the team and patient was referred to hospice. While awaiting for hospice placement, the patient experienced sever lower abdominal pain. At first we focused mainly on pain regimen, but due to the nature of the pain, bladder scan was obtained which showed urinary retention. Foley placement resolved his pain. This was very interesting to share because his residual kidney function was underrecognized and reversible source of pain should still be explored. We decided to work on this project to heighten the awareness of urinary obstruction as a rare etiology of reversible pain, even for patient withdrawing from HD.

23
Q

04- 04. Ito F, Sato T, Horiuchi K, Arai D, Ohgino K, Ishioka K, Terai H, Ikemura S, Yasuda H, Nakachi I, Kawada I, Inoue T, Oyamada Y, Terashima T, Sayama K, Fujisawa D, Takeuchi D, Fukunaga K, Naoki K, Soejima K. Health insurance and its psychosocial correlates in patients with advanced lung cancer in Japan. Support Care Cancer. June 2024.

A

This is one of the projects that I took part when I was in Japan. Based on a questionnaire obtained from patients with lung cancer and their caregivers, we were investigating correlates with their insurance status and social/psychological well-being. A large proportion of patients were old. Patients with insurance tend to maintain their psychological well-being and tend to be socially well supported. This is more about correlation rather than cause and effect, but was an interesting perspective. I had a role in gathering data.

24
Q

05-Okada M, Ohgino K, Horiuchi K, Ikemura S, Kawada I, Sayama K, Arai D, Watase M, Kobayashi K, Terashima T, Ishioka K, Miyawaki M, Sakamaki F, Masuzawa K, Kinoshita K, Terai H, Yasuda H, Soejima K, Fukunaga K. Real-world efficacy and safety of atezolizumab for advanced non-small cell lung cancer; a retrospective multicenter analysis. Clin Lung Cancer. January 2024.

A

This is a project that I took part when I was in Japan. This is a multicenter retrospective analysis to describe the real-world efficacy of atezolizumab for patients with lung cancer. Atezolizumab is one of the immune checkpoint inhibitors. Since there were a large proportion of older patients, we were trying to focus on how geriatric features correlates to treatment outcomes and toxicities. I mainly took a role in gathering data. There were no surprising correlates, maybe because this is not cytotoxic agent.

25
Q

01- (Accepted) Horiuchi K, Kuno T, Takagi H, Afezolli D. International Society of Geriatric Oncology 2024 Annual Conference. Poster presented: Predictive value of the Cancer and Aging Research Group Geriatric score for chemotherapy toxicities in older adults with cancer: a systematic review and meta-analysis. Montreal, QC; 10/18/2024.

A

This is similar to my other work as a chief investigator for the G8 project. It has been my strong desire to work on a research project to fill in the gaps between geriatrics and oncology. Last project was about cancer surgical population, and this one is about cancer chemotherapy population. By conducting a systematic review and a meta-analysis, I explored the predictive value of the CARG score for chemotherapy toxicity in older patient undergoing chemotherapy.
This field has a lot to be explored. There has been several RCTs supporting geriatric assessment guided cancer care, that it improves QOL, treatment completion rate, and less toxicity. CARG score is an important piece of practical geriatric assessment.
The CARG score is a 0-23 points screening tool that can be easily applied. Our meta-analysis revealed that the CARG score has the predictive value for chemotherapy toxicity.
Again, I am thrilled to work on a project in align with my vision.

26
Q

05-(Awarded 2nd place in Cases Category) Horiuchi K, Wijesinghe R, Uemura T, Kanei Y. The American Geriatrics Society 2024 Virtual Annual Scientific Meeting. Poster presented: Late presenting ST-elevation myocardial infarction complicated by left ventricular thrombus in a patient with dementia. Virtual, UA; 05/10/2024.

A

I presented this case to AGS, and was honored 2nd place in the cases category. This case is about an older patient with dementia presenting to the ED with chest pain, EKG showing STEMI. However, there were already a mixed picture of Q waves and T wave inversion, and it was not clear when the onset was. Patient had dementia and could not explain the onset either. TTE showed a widely stretched LV thrombus and altogether this was convincing for late presenting STEMI, which is more that 48 hrs after onset. The decision of onset is important, because after 48 hrs, there is no mortality benefit with catheter. The morphology of the LV thrombus was not well reported in the literature, so we decided to present this case as an additional piece to support late onset.

27
Q

09-Horiuchi K, Kushimoto K, Oashi A, Ochi J, Saito F, Yamamoto J. The 42nd Annual Meeting of The Japanese Society for Respiratory Endoscopy. Poster presented: A case of a bronchial tumor found in a patient being treated as difficult-to-treat asthma. Tokyo; 07/04/2019.

A

It was when I was PGY 5 that I experienced this case. This patient was a woman in her 40s was referred for difficult to treat asthma. Her wheezes persisted despite multiple inhalers and oral steroids. Bronchoscopy revealed a mass in the left bronchus, and resection resolved her symptoms. This was such a surprising case, with a lesson that all that wheezes are not asthma.

28
Q

09-Horiuchi K, Lee K, Ohgino K, Tanaka K, Omori N, Sayama K. The 58th Annual Meeting of The Japanese Respiratory Society. Poster presented: Clinical evaluation of 10 non-small cell lung cancer patients with PD-L1 expression over 80% treated with immune checkpoint inhibitors. Tokyo; 04/28/2018.

A

This was a single armed, retrospective analysis to evaluate the efficacy of immune checkpoint inhibitors in patients with extremely high PD-L1, which is an indicator for high efficacy to immune checkpoint inhibitors. Overall, they showed good response and progression free survival.

29
Q

02- Horiuchi K, Fogel J. Challenges in older patients with cancer and chemotherapy toxicity. Oral presentation: Resident Grand Rounds 2024, Icahn School of Medicine at Mount Sinai; 02/27/2024. New York, NY.

A

This was one of the exciting lectures that I delivered to the audience of the residency program. My lecture was mentored by the department of Geriatrics and Palliative Medicine, and I went over the updates for older cancer chemotherapy population based on the new geriatric oncology guideline by ASCO updated last year, supported by the international society of geriatric oncology. There has been a few RCTs randomizing CGA guided care vs standard of care, and resulted in improved chemotherapy completion rate, less toxicity, and better quality of life.
It was a good opportunity to review recent updates in align with my career vision, and such an exciting moment to share my passion with my peers.
Keywords;
-GAP70+ study
-Barriers; geriatric features, different preference toward treatment, under-represented in clinical trials
-GA domains; physical, functional, comorbidity, cognition, nutrition, social, polypharmacy, psychological

30
Q

03- (Invited Speaker) Horiuchi K, Uemura T. The differences between the US and Japan in communicating prognostic information in cancer patients. Oral presentation: The New Jewish Home’s 20th Annual Palliative Care Conference; 12/06/2022. New York, NY.

A

This was one of my precious experiences, being invited as a guest speaker at the New Jewish Home Palliative Care Conference. This is a local conference that Mount Sinai hosts, and hundreds of health care related experts attend. I had the opportunity to speak any topic related to palliative care, so I decided to share cultural differences in sharing prognostic information US vs Japan. I thought it would be interesting to put together my background and my future interest.
So I put together my experience as an oncologist, and my literature review of the topic. Japanese tend to prefer less disclosure and US tend to prefer more direct disclosure. I came across an interesting study based on questionnaire to Japanese decendants living in New York, and study showed that For Japanese immigrant population, there is more acculturation towards advanced generation which they would prefer more prognostic disclosure (Study from Sinai Japanese Practice). Very interesting to see that practicing in the US it is not cultural difference, but you also have to take into account immigration dynamics and be flexible as well.

31
Q

08- Horiuchi K, Nakahara J, Yoshizaki T, Suzuki S, Shimizu T, Takahashi S, Kanai T, Suzuki N. A case of newly diagnosed myasthenia gravis 43 years after thymectomy in a patient with ulcerative colitis. Oral presentation: The Japanese Society of Internal Medicine Kanto Branch 2017; 09/09/2017. Tokyo.

A

It was when I was PGY 3 that I experienced this case. This patient was a woman in her 80s who presented with weakness. Further work-up revealed the diagnosis of myasthenia gravis. This case was unusual because it was 40 years after thymectomy, and had a late onset. (It is outside from the common demographics)

32
Q

1-mentor in case report projects

A

This is one thing I have been putting a lot of effort in recent years. Over the past 5 years, I enjoyed engaging in multiple case report projects. It has been exciting, thrilling to find a new perspective from academic standpoint. Each patient is unique in their own way. I gradually became confident and mature with the process, and started mentoring projects. So far, I have had four mentees and they all have been successful with their presentations and publications. I overall enjoyed exploring my role, connecting them to their senior mentors, discussing academic contents and personal issues. Mentoring skill is definitely something that I am hoping to keep learning.

33
Q

2-Chief investigator in G8 project

A

It was my strong desire to work on a research project to fill in the gaps between geriatrics and oncology. This is my very first one, mentored by the Department of Geriatrics and Palliative Medicine. By conducting a systematic review and meta-analysis, I explored the predictive value of the G8 screening tool for post operative complications in older adults who are undergoing cancer surgery. Happily, this was published in the Journal of Geriatric Oncology.
It was a great collaboration with my mentors and statistician, and such a great pleasure to work on a project that is in align with my vision, based on my own clinical question.
G8; 0-17. Fit 17-15. Not fit 14-0. Domains (8)-age, nutrition, physical, psychological,
medication, and self-reported health.

34
Q

3-facilitator in Japan team oncology program

A

This is a team building and leadership workshop produced by MD Anderson Cancer Center. I started off as a participant in 2019, and being selected as the most outstanding participant, I was invited to MDACC for 1 month with financial support as an award, and subsequently joined the workshop as a facilitator.
Facilitators and participants are from diverse discipline including physicians, nurses, pharmacists, chaplains and social workers. It is a three day course. First day is lecture on team building and leadership skills. Day 2 is group work on a project, where multidisciplinary team come together and apply their skills. Day 3 is Group presentation of their work. The whole aim was to build a foundation of team building and leadership in cancer care. My role is to facilitate participants utilizing team building and leadership skills in their group work, carefully observing the team dynamics and conflicts they are trying to overcome.
We prepare monthly for this workshop, and it is such a pleasure to be an active learner for this field.
Key words-
Storming-norming-performing. Team dynamics
Inclusiveness, psychological safety, diversity

35
Q

4-chief investigator in CARG study

A

This is similar to my other work as a chief investigator for the G8 project. It has been my strong desire to work on a research project to fill in the gaps between geriatrics and oncology. Last project was about cancer surgical population, and this one is about cancer chemotherapy population. By conducting a systematic review and a meta-analysis, I explored the predictive value of the CARG score for chemotherapy toxicity in older patient undergoing chemotherapy.
This field has a lot to be explored. The CGA- comprehensive geriatric assessment, is known for its multi-dementional evaluation followed by geriatric intervention. The CGA guided cancer care is known to decrease toxicity and maintain function for older patients, highly collaborating with oncologists. The downside of CGA is that it is not easily applicable and it is not clear who benefits from CGA. There were a need for an easier screening tool to risk stratify chemotherapy toxicity to figure out who benefits from CGA. The CARG score is a 0-23 points screening tool that can be easily applied. Our meta-analysis revealed that the CARG score has the predictive value for chemotherapy toxicity.
This will be presented at the International Society of Geriatric Oncology this October, and publication is in process. Again, I am thrilled to work on a project in align with my vision.

36
Q

5-attending in Tokyo Medical Center

A

I finished my residency and fellowship in Japan, and worked as an attending for a year, in Pulmonary Medicine and Thoracic Medical Oncology. This was an amazing experience, overseeing residents and fellows providing them with support and structuring a safe team culture so that we could highly function. My main clinical focus was lung cancer, so I was dealing with diagnosis, chemotherapy, and end-of-life. There was good longitudinal relationship with cancer patients because I did outpatient chemo, and inpatient service myself. That is also where I struggled to provide appropriate care for older patients with serious illness, which has been my driving force.

37
Q

6-Member, TORG

A

Thoracic Oncology Research Group is an organization composed of multiple institutions, and it is aimed to conduct multicenter prospective clinical research studies. I am a member of the clinical research training program and through this program we brush up our skills in data management and critical thinking. I hope I can apply these skills when conducting my research in geriatrics and palliative care.

38
Q

7-Chief investigator in Keio University

A

As a chief investigator in the field of thoracic medical oncology in Japan, I handled several research projects. One of the project that I put a lot of effort in, is the research studying the correlates of interstitial lung disease and immune checkpoint inhibitor related pneumonitis.
This is a single institution retrospective research to collect a real-world data to evaluate whether underlying interstitial lung abnormalities be a risk factor for pneumonitis, associated with immune checkpoint inhibitors. This was one of the exciting projects that I engaged in, since this was generated from my own clinical question and I took a leadership role. This research involved many cancer related departments including dermatology, urology, GI, pulmonology, hematology, and radiology. This experience was meaningful because a high level leadership, team building, and coordination were required, which I was able to build through the journey.

39
Q

8-Fellow in Keio University Affiliated Hospitals

A

During my fellowship years in Japan, I focused on Pulmonary Medicine and Thoracic Medical Oncology. I rotated widely across university affiliated hospitals, some high volume center and some more closer to the community. I had the joy and struggle taking care of each patient, since there was a longitudinal relationship for cancer patients that came to my outpatient clinic and inpatient service. I also started writing up case report projects during that time, and realized that each patient is unique in their own way. The excitement of sharing new academic perspectives, was definitely something I enjoyed through those years.

40
Q

9-Senior resident at Keio University

A

During my senior resident year, I worked at one of the nation’s largest university
hospitals. I had the opportunity to rotate across numerous specialties, including
Pulmonology, Cardiology, Gastroenterology, Rheumatology, Neurology, Nephrology,
Endocrinology, and Hematology/Oncology. These rotations provided me with exposure
to complex treatments and care that are typically not available in community hospitals.

41
Q

10-junior resident at Yokohama Minato Redcross Hospital

A

My career as a physician began in a large community-based, high-volume center
known for accepting the largest number of ambulances in the nation. During this time, I
rotated through departments such as Internal Medicine, Surgery, Pediatrics, Obstetrics
and Gynecology, Emergency Medicine, and Critical Care Medicine. These rotations
provided me with a wide variety of clinical exposures that honed my basic skills and
attitude as a healthcare professional.

42
Q

52, Tell me about the impactful experience written in your application
(transition to residency to the US with family)

A

Coming to the United States for residency was a major challenge for me and my family. Not only overcoming difference in cultures and languages, I had a role to maintain my family’s well-being while they struggle through this transition. Residency itself has a very tight schedule and comes with steep learning curve. Overall these two were extremely difficult to juggle. It sounds like a challenge, but this made the family’s bond stronger. Also, there has been a beauty of exploring something new. Overall, we are enjoying our journey.

43
Q

53, You seem to have many awards, could you tell us about it?

A

Yes, there are small ones, big ones, and meaningful ones. Small one would be alumni scholarship from my University group to support my clinical training. Bigger one is a grant in aid for young scientists, which helped me pursue my obligation as chief investigator, which came in 40,000 USD/2 years. The most meaningful one to me, was invitation to MD Anderson Cancer Center with financial support and being selected as a committee member of the Team Science Oncology Workshop. This opened up the door to be a lifelong learner for team building and leadership skills.